Healthcare Industry News: crush
News Release - May 20, 2008
Ohio State University Medical Center to Test Efficacy of Hyperbaric Oxygen Medicine on Stroke Victims
ANAHEIM, Calif., May 20 (HSMN NewsFeed) -- With the financial support of Sechrist Industries, Inc., The Center for Minimally Invasive Surgery (CMIS) at the Ohio State University Medical Center has begun testing the efficacy of hyperbaric oxygen medicine on experimental stroke models. CMIS is a multidisciplinary center dedicated to excellence in patient care, clinical training, research and outcomes studies pertaining to the techniques and technology of minimally invasive surgery.Currently utilized for the treatment of chronic, non-healing wounds, carbon monoxide poisoning, crush injuries as well as other indications, the use of hyperbaric medicine for stroke victims is at the forefront of hyperbaric research. Hyperbaric oxygen therapy is the treatment of the entire body with 100-percent oxygen at greater than normal atmospheric pressures. Hyperbaric medicine greatly increases oxygen concentration in all body tissues, even with reduced or blocked blood flow, stimulates the growth of new blood vessels to locations with reduced circulation (improving blood flow to areas with arterial blockage) and causes a rebound arterial dilation after treatment, resulting in an increased blood vessel diameter greater than when therapy began, thus improving blood flow to compromised organs. The CMIS team is hopeful that these benefits of hyperbaric oxygen treatments will positively affect stroke patients.
"Ohio State University Medical Center is one of the finest health care institutions in the country," stated Jack Rollins, President and CEO of Sechrist Industries, Inc. "As the world leader in hyperbaric oxygen technology, we feel that it is important to join forces with CMIS to support research in the field of hyperbaric medicine."
"We believe that there is a window of opportunity to treat stroke related injury of the brain using hyperbaric oxygen. The challenge lies in accurately defining the perimeters of that window," says Chandan Sen, Director of the Comprehensive Wound Center at the Ohio State University Medical Center.
For additional information, contact Monica Gutierrez (mgutierrez@sechristusa.com) or visit http://www.sechristusa.com.
ABOUT Sechrist Industries -- Sechrist is the leading manufacturer of monoplace HBO chambers in the USA, and supplies more monoplace chambers than all other manufacturers combined with over 2000 installed around the world.
Source: Sechrist Industries
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
